Key observations:
Terminology considerations:
YNL276C appears to follow yeast ORF nomenclature (Y = yeast, NL = chromosome location)
No yeast-derived therapeutic antibodies currently target human antigens matching this designation
Hypothetical scenarios:
Preclinical research: May refer to an unpublished monoclonal antibody in early development
Nomenclature error: Potential typographical error in identifier (e.g., YNL275C or YNL276D)
Proprietary compound: Could be an internal code name not yet disclosed in public domains
For researchers seeking information about YNL276C:
Contact:
Saccharomyces Genome Database (SGD) for yeast ORF verification
Patent offices for unpublished applications (e.g., WO/2024 searches)
Experimental validation:
Perform BLAST search against antibody sequence databases
Use structural prediction tools (AlphaFold, RosettaAntibody)
Alternative sources:
Check conference abstracts from immunology meetings (2023-2025)
Request information from commercial antibody manufacturers directly
YNL276C is a putative uncharacterized protein in Saccharomyces cerevisiae with a molecular weight of approximately 14,116 Da . This protein has garnered research interest primarily in the context of yeast genetics and chromatin organization studies. YNL276C appears in research investigating chromatin dynamics, particularly in relation to histone variants like Htz1 and chromatin-remodeling complexes such as SWR1 . While its precise function remains to be fully characterized, studying YNL276C contributes to our understanding of yeast genome organization and gene expression regulation.
YNL276C antibodies are primarily employed in fundamental research techniques for protein detection and localization. The most common applications include:
| Application | Primary Use Case | Typical Dilution Range |
|---|---|---|
| Western Blot (WB) | Protein detection and quantification | 1:500 - 1:2000 |
| ELISA | Quantitative protein measurements | 1:1000 - 1:5000 |
| Chromatin Immunoprecipitation (ChIP) | Protein-DNA interaction studies | 1:100 - 1:500 |
These applications allow researchers to investigate YNL276C expression patterns, protein-protein interactions, and potential chromatin associations. The antibody has been validated specifically for Western Blot and ELISA according to technical documentation .
YNL276C antibodies are typically generated using recombinant protein as the immunogen. In particular, commercially available antibodies use recombinant Saccharomyces cerevisiae (strain 204508/S288c) YNL276C protein as the immunizing antigen . The antibodies are predominantly available as:
Polyclonal antibodies: Generated in rabbits and purified through antigen-affinity methods . These provide broad epitope recognition but may exhibit batch-to-batch variation.
Monoclonal antibodies: Less common for YNL276C, but would provide consistent single-epitope recognition.
The standard format is non-conjugated liquid antibody, preserved in solutions containing glycerol (typically 50%) and preservatives like Proclin 300 (0.03%) in phosphate-buffered saline (0.01M PBS, pH 7.4) .
YNL276C antibodies have been used in chromatin immunoprecipitation (ChIP) studies, though typically with varying efficiency compared to well-characterized chromatin protein antibodies. Research comparing the localization of chromatin-associated proteins indicates that YNL276C may be studied in relation to chromatin remodeling complexes like SWR1 .
Comparative ChIP efficiency data from studies investigating multiple yeast proteins suggests:
The relatively limited information about YNL276C localization highlights the need for further research using optimized ChIP protocols with appropriate controls.
Cross-reactivity is a significant consideration when using YNL276C antibodies in comparative studies across different yeast species or other organisms. Since YNL276C is a Saccharomyces cerevisiae protein, cross-reactivity depends on sequence conservation with homologs in other species.
Researchers should consider:
Sequence homology verification: Before using the antibody in non-S. cerevisiae species, conduct sequence alignment analysis to identify potential homologs and epitope conservation.
Cross-reactivity testing: Western blot validation using lysates from multiple species to confirm specificity before proceeding with more complex experiments.
Negative controls: Include samples from organisms lacking YNL276C homologs or YNL276C knockout strains to establish baseline non-specific binding.
While available YNL276C antibodies are generated against and validated for S. cerevisiae strains such as S288c , comprehensive cross-reactivity data across multiple yeast species remains limited in the published literature.
YNL276C antibodies can serve as valuable tools in investigating potential roles of this protein in gene expression regulation. Multiple experimental approaches can be employed:
ChIP-Seq analysis: Combining YNL276C ChIP with next-generation sequencing can identify genome-wide binding patterns and potential associations with specific genomic elements or other regulatory proteins.
Co-immunoprecipitation (Co-IP): Identifying protein interaction partners of YNL276C using antibody-based pull-down followed by mass spectrometry.
Expression correlation studies: Comparing YNL276C localization data with transcriptional profiles of genes like RDS1 (YCR106W) and UBX3 (YDL091C), which show expression changes in chromatin-associated protein mutants .
Research focused on chromatin-associated proteins indicates methodologies that could be applied to YNL276C studies. For instance, quantitative analysis of gene expression in mutant strains (similar to arp6- and htz1-deletion studies ) could reveal potential regulatory functions of YNL276C.
Optimizing Western Blot protocols for YNL276C detection requires addressing several parameters:
Sample preparation:
Extract proteins using methods that preserve native conformation
For yeast cells, glass bead lysis in buffer containing protease inhibitors is recommended
Include reducing agents like DTT or β-mercaptoethanol in the sample buffer
Electrophoresis and transfer conditions:
Antibody incubation:
Initial dilution testing: Try 1:500, 1:1000, and 1:2000 dilutions
Incubate primary antibody overnight at 4°C with gentle agitation
Use 5% non-fat dry milk or BSA in TBST for blocking and antibody dilution
Detection optimization:
Enhanced chemiluminescence (ECL) systems provide suitable sensitivity
Consider longer exposure times (2-5 minutes) if signal is weak
Researchers should verify expected molecular weight (14,116 Da for YNL276C) and validate results with appropriate controls, including YNL276C deletion strains when available.
Rigorous experimental design with appropriate controls is crucial for generating reliable data with YNL276C antibodies:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive Control | Confirm antibody functionality | Use purified recombinant YNL276C protein or wild-type yeast lysate |
| Negative Control | Assess non-specific binding | YNL276C deletion strain lysate |
| Loading Control | Normalize protein amounts | Anti-actin (ACT1) or anti-GAPDH antibodies |
| Secondary Antibody Control | Evaluate background | Omit primary antibody, apply only secondary antibody |
| Isotype Control | Assess non-specific binding | Irrelevant antibody of same isotype and concentration |
For ChIP experiments, additional controls should include:
Input samples (pre-immunoprecipitation)
Non-specific IgG precipitation controls
Positive control regions (known binding sites of other well-characterized proteins)
Negative control regions (transcriptionally inactive regions)
These controls are particularly important given that YNL276C is a putative uncharacterized protein, requiring stringent validation of antibody specificity and experimental results.
Proper storage and handling are critical for maintaining antibody performance over time:
Storage conditions:
Working solution preparation:
Stability considerations:
Monitor performance periodically using consistent positive controls
Document lot numbers and prepare new working dilutions if performance diminishes
Consider adding protein stabilizers (BSA 1-5 mg/ml) to working dilutions
Following these practices helps ensure consistent performance across experiments and extends the useful life of valuable antibody reagents.
When experiments with YNL276C antibodies yield suboptimal results, systematic troubleshooting is necessary:
No signal in Western blot:
Verify protein transfer (use reversible stain like Ponceau S)
Increase antibody concentration (try 2-5× more concentrated)
Extend primary antibody incubation time or temperature
Check detection system functionality with positive control antibodies
High background:
Increase blocking time or concentration
Add 0.1-0.5% Tween-20 to washing buffers
Decrease antibody concentration
Try alternative blocking agents (switch between milk and BSA)
Multiple bands or unexpected molecular weight:
Verify sample preparation (add fresh protease inhibitors)
Check for post-translational modifications or degradation
Test alternative reducing conditions
Evaluate antibody specificity with additional validation tests
Poor reproducibility:
Standardize protocols with detailed documentation
Control for variables like incubation times and temperatures
Use the same lot number when possible
Prepare larger volumes of working solutions for consistent experiments
For ChIP experiments specifically, optimization of crosslinking conditions, sonication parameters, and antibody concentration are critical variables that may require systematic adjustment.
Integration of YNL276C antibody-based research with complementary proteomics methods creates a more comprehensive understanding:
Mass spectrometry validation:
Confirm antibody-detected proteins through peptide mass fingerprinting
Identify post-translational modifications missed by antibody detection
Quantify protein abundance changes in different conditions
Protein interaction network mapping:
Compare antibody-based co-IP results with yeast two-hybrid screening data
Cross-reference with published protein interaction databases
Validate interactions with reciprocal pull-downs
Functional genomics correlation:
Integrate antibody-based localization data with phenotypic screens
Compare protein expression patterns with transcriptomics data
Correlate with genetic interaction networks from genome-wide studies
This multi-omics approach is particularly valuable for studying putative uncharacterized proteins like YNL276C, where function may be inferred from interaction partners and response patterns.
YNL276C antibodies could provide insights into potential associations with chromatin remodeling complexes like SWR1, which is involved in histone variant exchange:
Comparative localization studies:
Functional association experiments:
Complex integrity assessment:
Co-immunoprecipitation to determine if YNL276C interacts with SWR1 complex components
Size exclusion chromatography followed by Western blot to determine if YNL276C exists in high molecular weight complexes
Density gradient fractionation to isolate intact complexes
The potential relationship between YNL276C and chromatin organization represents an exciting research direction where specific antibodies serve as essential investigative tools.